Gene Information: unc-103

Nameunc-103 View on WormBase
Species C. elegans
SequenceC30D11.1
Genetic positionIII:-3.79 +/- 0.005 cM
Genomic positionIII: 4115385..4147278

Strains carrying this gene

Strain Genotype Description
CB1597 unc-103(e1597) III. Semidominant. Paralyzed Unc. Prone to spontaneous suppression.
CG289 unc-103(n1213) pha-1(e2123) III; him-5(e1490) V;rgEx81. rgEx81[pha-1(+) + unc-103 promoter E::unc-103 genomic DNA]. Maintain at 20C.
CG490 unc-103(n1213) III; egl-2(rg4) him-5(e1490) V; rgEx173. rgEx173 [unc-103ep::egl-2(cDNA) + gtl-1p::CFP]. Pick animals with cyan fluorescence in their intestines. rgEx173 rescues food deprivation's ability to suppress unc-103(n1213)-induced male sex muscle seizures.
CG499 daf-2(e1368) unc-103(n1213) III; him-5(e1490) V; rgEx178. rgEx178 [lev-11p::daf-2(+) + lev-11p::GFP]. rgEx178 rescues food deprivation suppression of unc-103(n1213)-induced spicule protraction.
CG500 daf-2(e1368) unc-103(n1213) III; him-5(e1490) V; rgEx180. rgEx180 [aex-3p::daf-2(+) + tnt-4p::GFP]. rgEx180 reduces unc-103(n1213)-induced spicule protraction, and rescues constitutive dauer formation.
CG625 unc-103(n1213) pha-1(e2123) III; him-5(e1490) V; rgEx235. rgEx235 [plc-3p::YFP + pha-1(+)]. Expresses YFP from a 4.4bk upstream plc-3 promoter. Maintain at 20C.
CG640 daf-2(e1368) unc-103(n1213) III; him-5(e1490) V; rgEx247. rgEx247 [hsp-16p::daf-2(+) + lev-11p::GFP]. rgEx247 restores food-deprivation suppression of unc-103(n1213)-induced spicule protraction.
MT2509 unc-103(n500) III. Semi-dominant Unc.
MT2633 unc-103(n500n1211) III. Non-Unc.
MT2635 unc-103(e1597n1213) III. Intragenic revertant.
MT2636 unc-103(e1597n1214) III. Revertant. WT phenotype.
PS4230 unc-103(sy557) III; him-5(e1490) V. Semi-dominant. 60% of adult males will have protruding spicules; Prc (protraction constitutive) phenotype. Larval animals and adult hermaphrodites do not display any gross abnormal phenotypes. Prc males have a mating efficiency of 0. Non-Prc males have a mating efficiency of 3. Do not distribute this strain; other labs should request it from the CGC. This strain cannot be distributed to commercial organizations. This strain cannot be used for any commercial purpose or for work on human subjects.